Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
A Year-End Look At HIV Treatments in 2013

Looking ahead into 2014, convenient combination treatments like Gilead's Stribild could substantially improve the daily lives of patients. In addition, newer integrase inhibitors like Isentress and Tivicay could chip away at the dominance of Viread-based drugs. HIV vaccines, now nearly three decades overdue, could eventually arrive as well. RV 144 and Inovio's HIV vaccines are two promising projects which could eventually save millions of lives and render HIV cocktail drugs from Gilead and ViiV Healthcare obsolete.

Published
29 December 2013
From
Motley Fool
Short course of ART during primary HIV infection has immunological and virological benefits after treatment is stopped

A short course of antiretroviral therapy during primary HIV infection (PHI) has immunological and virological benefits after treatment is stopped, a meta-analysis published in the online journal PLoS

Published
27 December 2013
By
Michael Carter
HIV drugs subsidy: regulatory barrier to be removed, granting broader access in Australia

A regulatory barrier previously prevented people with HIV who did not show clinical symptoms and who had higher “CD4” counts from accessing antiretroviral drugs through the PBS until either they began showing symptoms or their cell count dropped.

Published
20 December 2013
From
The Guardian
Botswana's ART programme achieves good results

Botswana’s antiretroviral treatment (ART) programme has achieved good results, analysis of nine years of data published in The Lancet Global Health shows. The overall mortality rate was 8%.

Published
20 December 2013
By
Michael Carter
Advances in HIV treatment dramatically increase life expectancy

An individual in North America beginning HIV treatment can now expect to live into their early 70s, a dramatic increase from just over 10 years ago, according to a new study from a collaboration of researchers led by the BC Centre for Excellence in HIV/AIDS (BC-CfE).

Published
19 December 2013
From
British Columbia Centre for Excellence in HIV/AIDS
New anti-HIV drug target identified

University of Minnesota researchers have discovered a first-of-its-kind series of compounds possessing anti-human immunodeficiency virus (HIV) activity. The compounds present a new target for potential HIV drug development and future treatment options.

Published
19 December 2013
From
Medical Xpress
Lupin launches HIV drug in the US

Drug major Lupin on Wednesday said it has launched the generic version of ViiV Healthcare’s (ViiV) Trizivir tablets in the US market with 180-days of marketing exclusivity.

Published
19 December 2013
From
The Hindu
Germans 'cut HIV out of infected cell'

Biomedicine researchers at Dresden's Technical University succeeded in curing several HIV-infected mice with the new method which uses an enzyme to cut the virus from the DNA of infected cells.

Published
18 December 2013
From
The Local.de
SF program pushes immediate HIV treatment for acute infection

A San Francisco program is aiming to get people newly diagnosed with acute HIV infection immediately into treatment - as in, taking antiretroviral drugs the same day they test positive.

Published
18 December 2013
From
San Francisco Chronicle
Health systems, not family factors, most crucial in PMTCT outcomes, Kenyan study shows

Women who learn of their HIV infection during pregnancy are at higher risk of vertical transmission of HIV than those who previously knew their status, according to

Published
17 December 2013
By
Lesley Odendal

Filter by country